Subcortical volumetric abnormalities in bipolar disorder
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023752%3A_____%2F16%3A43915190" target="_blank" >RIV/00023752:_____/16:43915190 - isvavai.cz</a>
Výsledek na webu
<a href="http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2015227a.html" target="_blank" >http://www.nature.com/mp/journal/vaop/ncurrent/full/mp2015227a.html</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1038/mp.2015.227" target="_blank" >10.1038/mp.2015.227</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Subcortical volumetric abnormalities in bipolar disorder
Popis výsledku v původním jazyce
Considerable uncertainty exists about the defining brain changes associated with bipolar disorder (BD). Understanding and quantifying the sources of uncertainty can help generate novel clinical hypotheses about etiology and assist in the development of biomarkers for indexing disease progression and prognosis. Here we were interested in quantifying case-control differences in intracranial volume (ICV) and each of eight subcortical brain measures: nucleus accumbens, amygdala, caudate, hippocampus, globus pallidus, putamen, thalamus, lateral ventricles. In a large study of 1710 BD patients and 2594 healthy controls, we found consistent volumetric reductions in BD patients for mean hippocampus (Cohen's d=MINUS SIGN 0.232; P=3.50 x 10MINUS SIGN 7) and thalamus (d=MINUS SIGN 0.148; P=4.27 x 10MINUS SIGN 3) and enlarged lateral ventricles (d=MINUS SIGN 0.260; P=3.93 x 10MINUS SIGN 5) in patients. No significant effect of age at illness onset was detected. Stratifying patients based on clinical subtype (BD type I or type II) revealed that BDI patients had significantly larger lateral ventricles and smaller hippocampus and amygdala than controls. However, when comparing BDI and BDII patients directly, we did not detect any significant differences in brain volume. This likely represents similar etiology between BD subtype classifications. Exploratory analyses revealed significantly larger thalamic volumes in patients taking lithium compared with patients not taking lithium. We detected no significant differences between BDII patients and controls in the largest such comparison to date. Findings in this study should be interpreted with caution and with careful consideration of the limitations inherent to meta-analyzed neuroimaging comparisons.
Název v anglickém jazyce
Subcortical volumetric abnormalities in bipolar disorder
Popis výsledku anglicky
Considerable uncertainty exists about the defining brain changes associated with bipolar disorder (BD). Understanding and quantifying the sources of uncertainty can help generate novel clinical hypotheses about etiology and assist in the development of biomarkers for indexing disease progression and prognosis. Here we were interested in quantifying case-control differences in intracranial volume (ICV) and each of eight subcortical brain measures: nucleus accumbens, amygdala, caudate, hippocampus, globus pallidus, putamen, thalamus, lateral ventricles. In a large study of 1710 BD patients and 2594 healthy controls, we found consistent volumetric reductions in BD patients for mean hippocampus (Cohen's d=MINUS SIGN 0.232; P=3.50 x 10MINUS SIGN 7) and thalamus (d=MINUS SIGN 0.148; P=4.27 x 10MINUS SIGN 3) and enlarged lateral ventricles (d=MINUS SIGN 0.260; P=3.93 x 10MINUS SIGN 5) in patients. No significant effect of age at illness onset was detected. Stratifying patients based on clinical subtype (BD type I or type II) revealed that BDI patients had significantly larger lateral ventricles and smaller hippocampus and amygdala than controls. However, when comparing BDI and BDII patients directly, we did not detect any significant differences in brain volume. This likely represents similar etiology between BD subtype classifications. Exploratory analyses revealed significantly larger thalamic volumes in patients taking lithium compared with patients not taking lithium. We detected no significant differences between BDII patients and controls in the largest such comparison to date. Findings in this study should be interpreted with caution and with careful consideration of the limitations inherent to meta-analyzed neuroimaging comparisons.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
AN - Psychologie
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Ostatní
Rok uplatnění
2016
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Molecular Psychiatry
ISSN
1359-4184
e-ISSN
—
Svazek periodika
21
Číslo periodika v rámci svazku
12
Stát vydavatele periodika
GB - Spojené království Velké Británie a Severního Irska
Počet stran výsledku
7
Strana od-do
1710-1716
Kód UT WoS článku
000388720600010
EID výsledku v databázi Scopus
2-s2.0-84995699210